Update on The Greater Cannabis Company
ST. PETERSBURG, FL / ACCESSWIRE / September 17, 2014 / Sylios Corp (OTC Pink:UNGS), is pleased to announce that it has retained a Connecticut-based investment banking firm as its financial advisor and investment banker to assist in the identification and structuring of potential acquisition transactions.
Sylios is a holding corporation with operations engaged in the exploration and development of oil and natural gas properties, investments in equities and corporate debt and the development of products utilized for the medical and recreational marijuana industry. A key element of the Company’s long-term strategy is to be a leader in the medical and recreational marijuana space by entering into key licensing agreements targeting first tier products and the acquisition of companies with products showing the potential for exponential growth.
The newly engaged investment banking firm, with a specialty in Mergers & Acquisitions, is in discussions with a number of companies in the areas of specialty healthcare, medical marijuana, payment processing, vaporizer and electronic inhalers and other verticals to complement the Company's path of growth through its subsidiary, The Greater Cannabis Company.
Wayne Anderson, President of Sylios Corp, noted, "We are excited to complete our first licensing agreement through our subsidiary The Greater Cannabis Company, and delighted to have the support of such outstanding financial advisors who truly understand our industry and what we are trying to accomplish. Sylios has identified half a dozen products and/or acquisition targets in the medical and recreational marijuana industry that would complement our business goals and path to profitability. We expect to update shareholders in the coming weeks on the progress of any discussions."
The Company will launch its website for The Greater Cannabis Company the week of September 29th. The Company website for its e-commerce store, GCC Superstore, will launch the second week of October 2014. The Company has entered into a reseller agreement with Atmos Rx for the sale of their cannabis related accessory products and is in discussions with two other premier manufacturers of accessory products. Upon the launch of GCC Superstore, the Company projects it will have 150+ SKUs (stock keeping units) within multiple categories.
About Sylios Corp
Sylios Corp, based in St. Petersburg, FL, is a holding corporation with operations engaged in the exploration and development of oil and natural gas properties, investments in equities and corporate debt and the development of products utilized for the medical and recreational marijuana industry. For more information on Sylios Corp, please visit www.sylios.com.
Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein, and while expected, there is no guarantee that we will attain the aforementioned anticipated developmental milestones. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company. Additional risks and uncertainties are set forth in the Company's Unaudited Annual Report for the year ended December 31, 2013, which can be found on the OTC Markets website, www.otcmarkets.com.
Contact:
Sylios Corp
(727) 821-6200
SOURCE: Sylios Corp